This Machine Learning startup helps breast cancer patients customise treatment, predicts risk of recurrence
This Machine Learning startup helps breast cancer patients customise treatment, predicts risk of recurrence
- This Machine Learning startup helps breast cancer patients customise treatment, predicts risk of recurrence
- OncoStem's product CanAssist-Breast helps early-stage cancer patients plan optimum chemotherapy treatment
- We are trying to solve this by developing innovative tests which assess the risk of cancer recurrence for early-stage cancer patients and which will help in optimum treatment planning," she explains.
- Clinicians use this information, along with other clinical patient specific information, to devise tailor-made therapeutic strategies for each patient.
- This will help clinicians and the patients to understand the disease better and plan a suitable treatment," she elucidates.